Fidelity Investments’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-432,220
Closed -$251K 5907
2024
Q3
$251K Sell
432,220
-1,176,151
-73% -$659K ﹤0.01% 3122
2024
Q2
$994K Buy
1,608,371
+564,468
+54% +$477K ﹤0.01% 2520
2024
Q1
$2.68M Sell
1,043,903
-941,391
-47% -$2.3M ﹤0.01% 2248
2023
Q4
$4.05M Buy
1,985,294
+1,131,696
+133% +$2.07M ﹤0.01% 2118
2023
Q3
$1.47M Buy
853,598
+63,282
+8% +$112K ﹤0.01% 2363
2023
Q2
$1.54M Sell
790,316
-8,197
-1% -$19.2K ﹤0.01% 2389
2023
Q1
$2.22M Buy
798,513
+8,061
+1% +$23K ﹤0.01% 2343
2022
Q4
$2.73M Buy
790,452
+198,242
+33% +$566K ﹤0.01% 2289
2022
Q3
$1.52M Sell
592,210
-396
-0.1% -$1.26K ﹤0.01% 2506
2022
Q2
$1.43M Buy
592,606
+453,302
+325% +$1.19M ﹤0.01% 2587
2022
Q1
$574K Sell
139,304
-1,928,847
-93% -$10.2M ﹤0.01% 2938
2021
Q4
$26.6M Sell
2,068,151
-983,707
-32% -$10.9M ﹤0.01% 1689
2021
Q3
$33M Buy
3,051,858
+256,445
+9% +$2.33M ﹤0.01% 1604
2021
Q2
$25.5M Sell
2,795,413
-22,694
-0.8% -$210K ﹤0.01% 1737
2021
Q1
$26.6M Sell
2,818,107
-52,877
-2% -$728K ﹤0.01% 1674
2020
Q4
$11.3M Buy
2,870,984
+431,118
+18% +$1.3M ﹤0.01% 1924
2020
Q3
$6.47M Sell
2,439,866
-1,400,304
-36% -$5.2M ﹤0.01% 1981
2020
Q2
$25.5M Sell
3,840,170
-1,402,901
-27% -$9.45M ﹤0.01% 1453
2020
Q1
$30.5M Sell
5,243,071
-127,852
-2% -$1.07M ﹤0.01% 1234
2019
Q4
$48.2M Buy
5,370,923
+4,884
+0.1% +$40.7K 0.01% 1228
2019
Q3
$46.3M Buy
5,366,039
+8,209
+0.2% +$82.9K 0.01% 1193
2019
Q2
$59.7M Buy
5,357,830
+2,438,449
+84% +$27.9M 0.01% 1137
2019
Q1
$38.8M Buy
2,919,381
+15,551
+0.5% +$208K ﹤0.01% 1321
2018
Q4
$44.9M Buy
2,903,830
+1,253,830
+76% +$23.9M 0.01% 1194
2018
Q3
$23.5M Buy
+1,650,000
New +$23.5M ﹤0.01% 1611

Other funds holding GRTS

Fidelity Investments's GRTS Position: Q4 2024 in Review

Fidelity Investments sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 432,220 shares — an estimated $251K sold.

Fidelity Investments first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $59.7M in Q2 2019. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Fidelity Investments reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 432,220 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $251K.
  • Fidelity Investments first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
  • Fidelity Investments's Gritstone bio, Inc. Common Stock position peaked at $59.7M in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.